Current Drug Metabolism

Editor-in-Chief

Ming Hu
University of Houston
College of Pharmacy
Houston, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor



Meet Our Editorial Board Member free to download

Volume:21   Issue: 14
Pp: 1069-1069
Su-Jun Lee
DOI: 10.2174/138920022114201230141909
Published on: 30 December, 2020



Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases & their Metabolic Profiling-Part 2 free to download

Volume:21   Issue: 14
Pp: 1070-1071
Bairong Shen and Rajeev K. Singla
DOI: 10.2174/138920022114201230142204
Published on: 30 December, 2020



Recent Advances in Treatment of Childhood Obesity

Volume:21   Issue: 14
Pp: 1072-1078
Walter Milano, Paola Ambrosio, Francesca Carizzone, Walter Di Munzio, Valeria De Biasio and Anna Capasso*
DOI: 10.2174/1389200221666200817112311
Published on: 30 December, 2020



Germacrone: A Potent Secondary Metabolite with Therapeutic Potential in Metabolic Diseases, Cancer and Viral Infections

Volume:21   Issue: 14
Pp: 1079-1090
Ammara Riaz, Azhar Rasul*, Nazia Kanwal, Ghulam Hussain, Muhammad Ajmal Shah*, Iqra Sarfraz, Rubab Ishfaq, Rabia Batool, Fariha Rukhsar and Şevki Adem
DOI: 10.2174/1389200221999200728144801
Published on: 30 December, 2020




Natural Compounds as Source of Aldose Reductase (AR) Inhibitors for the Treatment of Diabetic Complications: A Mini Review

Volume:21   Issue: 14
Pp: 1091-1116
Ajmer Singh Grewal, Komal Thapa, Neha Kanojia, Neelam Sharma and Sukhbir Singh*
DOI: 10.2174/1389200221666201016124125
Published on: 30 December, 2020




Pharmacokinetic Research Progress of Anti-tumor Drugs Targeting for Pulmonary Administration

Volume:21   Issue: 14
Pp: 1117-1126
Mengfan Zhao, Ziwei Jing, Lin Zhou, Hongyu Zhao, Qiuzheng Du* and Zhi Sun*
DOI: 10.2174/1389200221999201111193910
Published on: 30 December, 2020




Metabolism and Interactions of Chloroquine and Hydroxychloroquine with Human Cytochrome P450 Enzymes and Drug Transporters

Volume:21   Issue: 14
Pp: 1127-1135
Slobodan Rendic* and Frederick Peter Guengerich
DOI: 10.2174/1389200221999201208211537
Published on: 30 December, 2020




Nanostructured Lipid Carriers (NLCs): Nose-to-Brain Delivery and Theranostic Application

Volume:21   Issue: 14
Pp: 1136-1143
Javed Ahmad*, Md. Rizwanullah, Saima Amin, Musarrat Husain Warsi, Mohammad Zaki Ahmad and Md. Abul Barkat
DOI: 10.2174/1389200221666200719003304
Published on: 30 December, 2020




Recent Advances in Nanotechnology: A Novel Therapeutic System for the Treatment of Alzheimer’s Disease

Volume:21   Issue: 14
Pp: 1144-1151
Pallavi Singh Chauhan, Dhananjay Yadav*, Bhupendra Koul, Yugal Kishore Mohanta and Jun-O Jin*
DOI: 10.2174/1389200221666201124140518
Published on: 30 December, 2020




Analysis of the Potential Association of Drug-Metabolizing Enzymes CYP2C9*3 and CYP2C19*3 Gene Variations With Type 2 Diabetes: A Case-Control Study

Volume:21   Issue: 14
Pp: 1152-1160
Imadeldin Elfaki*, Rashid Mir, Faisel Mohammed Abu-Duhier, Chandan Kumar Jha, Adel Ibrahim Ahmad Al-Alawy, Abdullatif Taha Babakr and Salem Abd El-Hadi Habib
DOI: 10.2174/1389200221999201027200931
Published on: 30 December, 2020




Different Effects of Polymorphic Flavin-Containing Monooxygenase 3 and Cytochrome P450 2A6 Activities on an Index of Arteriosclerosis as a Lifestyle-Related Disease in a General Population in Japan

Volume:21   Issue: 14
Pp: 1161-1164
Mirai Uraoka, Makiko Shimizu, Yoshiki Kuwajima, Ami Mizugaki, Haruka Yokoyama, Kanae Mure and Hiroshi Yamazaki*
DOI: 10.2174/1389200221666201009140802
Published on: 30 December, 2020




Acknowledgements to Reviewers free to download

Volume:21   Issue: 14
Pp: 1165-1166

DOI: 10.2174/138920022114201230145959
Published on: 30 December, 2020